Abstract
Arachidonic acid is metabolised either by cyclooxygenases to produce prostaglandins and thromboxanes or by lipoxygenases to produce mono-, di- and trihydroxyeicosatetraenoic acids (HETEs). Polymorphonuclear leukocytes (PMNs) release HETEs, including mono- and dihydroxy fatty acids, when exposed to stimuli such as the cakvim ionophore A23187 (refs 1, 2). The mono-HETEs are assumed to be of particular importance with respect to effects on leukocyte function because they have been shown to possess both chemotactic and chemokinetic activities towards PMNs and eosinophils3,4. However, we have now shown that the chemokinetic and aggregating activities released from rat and human PMNs exposed to ionophore A23187 (ref. 5) are not due to the release of mono-HETEs but to that of 5,12-di-HETE (leukotriene B). This compound is active over the concentration range 10 pg ml−1 to 5 ng ml−1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Borgeat, P. & Samuelsson, B. Proc. natn. Acad. Sci. U.S.A. 76, 2148–2152 (1979).
Stenson, W. I. & Parker, C. W. J. clin. Invest. 64, 1457–1465 (1979).
Goetzl, E. J. & Sun, F. F. J. exp. Med. 150, 406–411 (1979).
Goetzl, E. J., Weller, P. F. & Sun, F. F. J. Immun. 124, 926–933 (1980).
Bray, M. A., Ford-Hutchinson, A. W., Shipley, M. E. & Smith, M. J. H. Br. J. Pharmac. (in the press).
Borgeat, P. & Samuelsson, B. J. biol. Chem. 254, 7865–7869 (1979).
Borgeat, P. & Samuelsson, B. J. biol. Chem. 254, 2643–2646 (1979).
Palmer, R. J., Stepney, R., Higgs, G. & Eakins, K. E. Prostaglandins (submitted).
Bokoch, G. M. & Reed, P. W. Biochem. biophys. Res. Commun. 90, 481–487 (1979).
Smolen, J. & Weissman, G. Advances in Prostaglandin and Thromboxane Research (Raven, New York, in the press).
Smith, M. J. H. & Walker, J. R. Br. J. Pharmac. (in the press).
Cunningham, F. M., Shipley, M. E. & Smith, M. J. H. J. Pharm. Pharmac. 32, 377–380 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ford-Hutchinson, A., Bray, M., Doig, M. et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286, 264–265 (1980). https://doi.org/10.1038/286264a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/286264a0
This article is cited by
-
Effects of oxidative stress caused by iron overload on arachidonic acid metabolites in MES23.5 cells
Journal of Biosciences (2022)
-
Non-volatile compounds in exhaled breath condensate: review of methodological aspects
Analytical and Bioanalytical Chemistry (2018)
-
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets
Current Allergy and Asthma Reports (2016)
-
Leukotrienes induce the migration of Th17 cells
Immunology & Cell Biology (2015)
-
Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist Protects Against Hippocampal Injury Induced by Transient Global Cerebral Ischemia and Reperfusion in Rats
Neurochemical Research (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.